GB843214A - Improvements in or relating to steroid compounds - Google Patents

Improvements in or relating to steroid compounds

Info

Publication number
GB843214A
GB843214A GB5072/57A GB507257A GB843214A GB 843214 A GB843214 A GB 843214A GB 5072/57 A GB5072/57 A GB 5072/57A GB 507257 A GB507257 A GB 507257A GB 843214 A GB843214 A GB 843214A
Authority
GB
United Kingdom
Prior art keywords
pregnene
acetate
triol
formate
bromo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5072/57A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of GB843214A publication Critical patent/GB843214A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)

Abstract

The invention comprises steroid compounds of the general formula: <FORM:0843214/IV(b)/1> wherein X represents <FORM:0843214/IV(b)/2> or = O and R and R1 represent hydrogen, the formyl radical or an alkanoyl radical containing not more than 8 carbon atoms, and the preparation thereof by heating a compound of the general formula: <FORM:0843214/IV(b)/3> wherein X represents <FORM:0843214/IV(b)/4> or = O and R and R1 represent the formyl radical or an alkanoyl radical containing not more than 8 carbon atoms with an alkali metal salt of an alkanoic acid containing not more than 8 carbon atoms such as sodium or potassium acetate, or an alkali metal formate, and, when R and R1 represent hydrogen in the above general formula of the 2-substituted-steroids, hydrolysing the resulting ester compound. The preferred reactants for the above process are 6-bromo-4-pregnane-17 a ,21-diol-3,11,20-trione 21-acetate and 6-bromo-4-pregnene-11b ,17 a ,21-triol-3,20-dione 11-formate 21-acetate which may be converted into 4 - pregnene - 2, 17 a , 21-triol-3,11,20-trione and 4-pregnene-2,11b 17 a , 21 - tetrol - 3, 20 - dione respectively as well as the corresponding 2,21-diesters defined above such as the 2,12-diacetates. In the examples, 4-pregnene-2, 17 a , 21-triol-3,11,20-trione and the 2, 21 - diacetate thereof, and 4-pregnane-2, 11b , 17 a ,21-tetrol-3,20- dione and the 11 - formate 2, 21-diacetate thereof are prepared. 6 - Bromo - 4 - pregnene - b 11,17 a ,21 - triol-3, 20 - dione 11-formate 21-acetate is prepared by brominating 4-pregnene-11b ,17 a ,21-triol 11-formate 21-acetate with N-bromo-succinimide. 1,4-Pregnadienes are prepared by treating the 2-substituted steroids of the above general formula with a dehydrating agent such as hydrogen bromide in acetic acid, e.g. the 21-acetate of dehydrocortisone may be prepared from the corresponding 2,21-diacetate-4-pregnene.
GB5072/57A 1955-01-11 1955-08-03 Improvements in or relating to steroid compounds Expired GB843214A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US843214XA 1955-01-11 1955-01-11

Publications (1)

Publication Number Publication Date
GB843214A true GB843214A (en) 1960-08-04

Family

ID=22184218

Family Applications (1)

Application Number Title Priority Date Filing Date
GB5072/57A Expired GB843214A (en) 1955-01-11 1955-08-03 Improvements in or relating to steroid compounds

Country Status (1)

Country Link
GB (1) GB843214A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8207151B2 (en) 2008-05-28 2012-06-26 Validus Biopharma Inc. Non-hormonal steroid modulators of NF-κB for treatment of disease
US9198921B2 (en) 2010-04-05 2015-12-01 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-κB for treatment of disease
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10857161B2 (en) 2008-05-28 2020-12-08 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kB for treatment of disease
US8334279B2 (en) 2008-05-28 2012-12-18 Validus Genetics Non-hormonal steroid modulators of NF-κB for treatment of disease
US8673887B2 (en) 2008-05-28 2014-03-18 Reveragen Biopharma, Inc Non-hormonal steroid modulators of NF-kB for treatment of disease
US8207151B2 (en) 2008-05-28 2012-06-26 Validus Biopharma Inc. Non-hormonal steroid modulators of NF-κB for treatment of disease
US9434758B2 (en) 2008-05-28 2016-09-06 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-κB for treatment of disease
US9649320B2 (en) 2008-05-28 2017-05-16 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-κB for treatment of disease
US11833159B2 (en) 2008-05-28 2023-12-05 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kB for treatment of disease
US10206933B2 (en) 2008-05-28 2019-02-19 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kB for treatment of disease
US9198921B2 (en) 2010-04-05 2015-12-01 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-κB for treatment of disease
US10000525B2 (en) 2010-04-05 2018-06-19 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-κB for treatment of disease
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
US11690853B2 (en) 2015-06-29 2023-07-04 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-κβ for treatment of disease
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions
US11471471B2 (en) 2019-03-07 2022-10-18 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Similar Documents

Publication Publication Date Title
GB843214A (en) Improvements in or relating to steroid compounds
GB869511A (en) Improvements in or relating to steroids and the manufacture thereof
US2694079A (en) Dehydrohalogenation process
GB1045979A (en) Improvements in or relating to 5,10-seco-5,19-cyclo-10-fluoro-steroids
GB843215A (en) Improvements in or relating to steroid compounds
AU523501B2 (en) 21 hydroxy 20 oxo 17 alpha pregnanes
GB935116A (en) New cyclopentanophenanthrene derivatives and processes for the production thereof
GB892620A (en) Cyclopentanophenanthrene derivatives
GB936391A (en) Process for the fluorination of steroids
GB806045A (en) Steroids
GB978540A (en) Improvements in or relating to the production of 16ª‰-alkylthio-17-oxo-steroids
GB877085A (en) Steroid compounds
GB843213A (en) Process for the production of pregnadienes
GB981544A (en) Improvements in or relating to compounds of the pregnane series
GB944716A (en) 10ª -fluoro steroids and their preparation
GB806162A (en) Steroidal compounds
GB944718A (en) New steroid compounds and processes for their preparation
GB902026A (en) New cyclopentanophenanthrene compounds and process for their manufacture
GB802004A (en) Improvements in or relating to 6-methyl steroid compounds
GB1117406A (en) Process for dehydrohalogenating organic compounds
GB759745A (en) Steroids
GB802003A (en) Improvements in or relating to 6-methyl steroid compounds
GB877227A (en) Improvements in or relating to the production of steroid compounds, and the compounds thus produced
GB949843A (en) Cyclopentanophenanthrene derivatives and process for their preparation
GB855800A (en) New cyclopentanophenanthrene derivatives and process for the production thereof